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Abstract: Constitutive or regulated membrane protein trafficking is a key cell biology process.
Transient receptor potential channels are somatosensory proteins in charge of detecting several
physical and chemical stimuli, thus requiring fine vesicular trafficking. The membrane proximal
or pre-S1 domain (MPD) is a highly conserved domain in transient receptor potential channels
from the vanilloid (TRPV) subfamily. MPD shows traits corresponding to protein-protein and
lipid-protein interactions, and protein regulatory regions. We have expressed MPD of TRPV1 and
TRPV2 as green fluorescente protein (GFP)-fusion proteins to perform an in vitro biochemical and
biophysical characterization. Pull-down experiments indicate that MPD recognizes and binds Soluble
N-ethylmaleimide-sensitive factor Attachment Protein Receptors (SNARE). Synchrotron radiation
scattering experiments show that this domain does not self-oligomerize. MPD interacts with
phosphatidic acid (PA), a metabolite of the phospholipase D (PLD) pathway, in a specific manner as
shown by lipid strips and Trp fluorescence quenching experiments. We show for the first time, to the
best of our knowledge, the binding to PA of an N-terminus domain in TRPV channels. The presence
of a PA binding domain in TRPV channels argues for putative PLD regulation. Findings in this study
open new perspectives to understand the regulated and constitutive trafficking of TRPV channels
exerted by protein-protein and lipid-protein interactions.
Keywords: Transient Receptor Potential (TRP) channels; exocytosis; biophysics; protein–protein
interactions; lipid-protein interactions
1. Introduction
Membrane protein localization in the plasma membrane depends on trafficking mechanisms,
such as exocytosis. Exocytosis is a regulated process that makes readily available a set of proteins in the
plasma membrane of excitable and non-excitable cells. SNARE-dependent exocytosis in excitable cells
involves proteins such as syntaxins (Stx), synaptotagmins (Syt), and snapins [1,2]. SNAREs coordinate
an intricate protein-protein interaction network that facilitates vesicle docking and fusion with the
plasma membrane. Soluble N-ethylmaleimide-sensitive factor Attachment Protein 25 (SNAP25) and
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plasma membrane anchored Stxs form a complex that allows vesicle docking by interacting with
vesicle anchored Syts. Binding of Syts to Stxs-SNAP25 complex is a calcium-dependent process [3,4].
Syts present a C-terminal domain that mediates Stxs interaction upon calcium binding, acting as
calcium sensors [3]. The Stxs C-terminal transmembrane domain is used to interact with voltage-gated
calcium channels [5], which is a suitable molecular mechanism to ensure proximity between calcium
gates and calcium-depedent vesicle fusion machinery. Snapin modulates exocytosis by enhancing the
interaction of Syts with SNAP25 [2].
Transient receptor potential (TRP) channels are somatosensory proteins that require plasma
membrane trafficking [6]. Some TRP channels act as mechanosensors, responding to physical and
chemical stimuli affecting membrane mechanical properties [7]. Among these, the TRPV1–4 subgroup
consists of four channels that respond to heat and osmolality changes, factors that affect membrane
properties [8]. TRPV1–4 channels localize in the plasma membrane, being trafficked through regulated
and constitutive pathways [6]. TRPV1 from the vanilloid subfamily [9] is trafficked via protein kinase
C (PKC)—dependent exocytosis by interacting with synaptotagmin (Syt) I and IX, and snapin [10].
TRPV2, the closest homolog of TRPV1 also interacts with Syt-IX and snapin [11], and is also trafficked
constitutively. For both SNAREs, the protein–protein interaction happens at the level of the cytosolic
N-terminal region of TRPV1, most likely in the ankyrin repeat domain (ARD) and the neighboring
pre-S1 membrane proximal domain (MPD) [10].
The ARD domain is a protein–protein interaction domain [12]; the MPD domain is, structurally,
a link between the N- and C-terminus of the channel [13], and, functionally, is a temperature
sensor in the TRPV1–4 subgroup [14]. The MPD is highly conserved among the TRPV1–4
subgroup. Through bioinformatics analysis, we have identified putative regulatory features such as
phosphorylation sites, and lipid binding features in this MPD [15]. The current study aims to describe
the biophysical determinants of the MPD domain, to understand whether this domain is capable of
driving protein–protein and lipid–protein interactions.
2. Results
2.1. TRPVs and SNARE-Protein MPD-Mediated Interaction
The interaction between TRPV1–2 and SNARE proteins such as SytIX and Snapin has been
previously described [10,11]. In Figure 1a, we show the interaction of a TRPV2 ARD-less truncation
(∆ARD-TRPV2-GFP) with SytIX and Snapin, arguing for the existence of another domain in the
N-terminus capable of driving the interaction rather than ARD. We use a pull-down approach to assess
whether MPD is enough to drive the interaction between TRPV1–2 and SytIX and Snapin (Figure 1b),
by using the TRPV1 and TRPV2 MPD (further called MPD1 and MPD2, respectively). MPD1 and
MPD2 have been expressed recombinantly as GFP-fusion proteins following a two-step purification
process (Figure S1). The pull-down experiment using GFP-trap beads indicates that the MPD is enough
to pull-down SytIX and Snapin in vitro (Figure 1b).
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Figure 1. Mapping of the TRPV interaction with SNARE proteins. (a) Co-IP of human
embryonic kidney 293 (HEK293) cells transfected with TRPV2 lacking N-terminal ARD domain
GFP-tagged (∆ARD-TRPV2-GFP) and Snapin-25 or Synaptotagmin-IX c-myc-tagged. The lysates
were immunoprecipitated with anti-c-myc. (b) In vitro pull-down assay using purified MPD region
from TRPV1 or TRPV2 channels GFP-tagged to pull-down c-myc-tagged Snapin or Synaptotagmin-IX
in lysates from HEK293 transiently transfected cells. MPDs-GFP were immobilized on GFP-Trap beads.
IP: immunoprecipitation; IB: immunoblotting. Co-IP experiments have been carried out in the absence
(−) and presence (+) of c-myc antibody to assess the specificity of the interaction.
2.2. MPD-Mediated Lipid Binding
Taking advantage of the recombinant expression of the MPD1 and MPD2 GFP fusion
proteins, we decided to test the lipid binding to MPD hypothesis from our previous study [15].
MPD1 and MPD2 were incubated with several lipids immobilized on a nitrocellulose membrane,
such as phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PI4P), phosphatidic acid (PA),
phosphatidylcholine (PC), phosphatidylserine (PS), and phosphatidylglycerol (PG). From all the
headgroups tested, both MPD GFP-fusion proteins bind to PA in a concentration-dependent manner
(Figure 2a). The GFP control did not bind to PA or any other lipid (Figure 2a). To confirm this
result, we took advantage of the Trp residues present in the MPD but not in GFP. We monitored Trp
fluorescence while incubating the MPD proteins with increasing concentrations of PC, PA, and PG
liposomes (Figure 2b). Independently of the lipid headgroup, when GFP is incubated with increasing
concentrations of liposomes, we observed a light scattering effect because of liposome aggregation
(Figure 2b). In the presence of the MPD incubated with PC or PG liposomes, a slight Trp quenching
is observed (circa (ca.) 25%). When MPD is incubated with PA liposomes, Trp quenching is about
60% at the highest liposome concentration, indicating a binding of PA liposomes to both MPD1 and
MPD2 (Figure 2b).
Figure 2. Interaction of MPD domain from TRPV1 and TRPV2 with phosphatidic acid (PA). (a) Blank
(only buffer), PI, PA, PI4P, PS, PC, or PG lipids were immobilized on nitrocellulose membranes at
concentrations (conc.) of 50, 100, or 200 µM. Purified recombinant GFP or MPD-GFP from TRPV1
or TRPV2 channels were incubated on the lipid-containing nitrocellulose membranes and detected
using an anti-GFP antibody. (b) Tryptophan quenching experiments. GFP tryptophan fluorescence
(emission at 333 nm) of free GFP or MPDs from TRPV1 or TRPV2 was monitored in the presence
of increasing concentrations of the different lipid polar head-groups (Phosphatidylcholine, POPC,
1,2-Dipalmitoyl-sn-glycero-3-phosphate (DPPA), and Phosphatidylglycerol (POPG)) liposomes.
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2.3. MPD Oligomerization State
During the MPD-GFP purification, an apparent molecular weight (MW) of ca. 50 kDa was
observed for the MPD-GFP constructs. The expected MW for these constructs was ca. 35 kDa, i.e.,
27 kDA GFP( plus 8 kDa for the MPD. Dimerization of GFP proteins is described in the literature [16],
so we compared GFP alone against our MPD-GFP constructs in an sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) (Figure 3a). In non-heated samples, Coomassie blue
and in-gel fluorescence show a GFP monomeric band at ca. 27 kDa, and MPD-GFP constructs at
ca. 50 kDa. Reducing agents such as dithiothreitol (DTT) could not disassemble the MPD-GFP
high-molecular weight species (Figure 3a). Sample boiling for 5–10 min in Laemmli buffer dissolved
these high-molecular weight species (as observed in Coomassie blue staining) but also prevented the
observation of GFP-fluorescence (Figure 3a). Figure 3a indicates the possibility that the MPD is driving
oligomerization, which could be an artifact promoted by high protein concentration. Synchrotron
small-angle X-ray scattering (SAXS) data shows that no MPD-GFP construct is aggregated in solution
(Figure 3b), and the probability function indicates that the radius of gyration (Rgyr) for both constructs
is centered at ca. 2.5 nm (Figure 3c), as is the expected Rgyr for a monomeric MPD-GFP protein.
Figure 3. Oligomerization state of MPD domain for TRPV1 and TRPV2. (a) SDS-PAGE of boiled and
not boiled MPD-GFP samples (heat +/−, respectively) and in the presence/absence of reducing agents
observed by Coomassie blue (CB, top) and in-gel fluorescence (iGF, bottom; F stands for fluorescent
molecular weight (MW) marker). Black and read arrows indicate the oligomeric and monomeric
bands, respectively. (b) SAXS scattering plot for the MPD-GFP constructs for TRPV1 and TRPV2.
(c) Probability distribution function for the MPD-GFP constructs for TRPV1 and TRPV2.
3. Discussion
Here we present our strategy to produce a recombinant fusion protein (Figure S1) containing the
conserved MPD domain for the TRPV1–4 subgroup (Figure 4a). The biophysical characterization of the
MPD domain in vitro indicates the potential of this domain to drive certain function at the cellular level.
Initial bioinformatics predictions [15], such as protein-protein and lipid-protein interactions have been
confirmed in vitro using biochemical and biophysical methods (Figure 1; Figure 2). Our results indicate
that the MPD is not an oligomerization domain per se (Figure 3), but its role in the oligomerization of
the channel in the context of the whole sequence cannot be ruled out, as discussed below.
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Figure 4. (a) The MPD domain is highly conserved within the TRPV1–4 subgroup. An orange
dotted line delimits the LSRKF and Fork motifs. (b) Illustrative tridimensional depiction of TRPV1
(protein data bank (PDB) code 5IRZ, in pink surface representation) embedded in a DPPC/DPPA
bilayer (grey surface) resulting from a membrane molecular dynamics (MD) equilibration trajectory
(1 nanosecond). The MPD domain for Chain A is depicted as a colored surface. DPPA molecules within
5 Å of the protein are depicted in orange, except for those DPPA molecules within 5 Å of Chain A
for TRPV1, which are depicted as Van der Wals (VdW) spheres colored by element (C in cyan; P in
golden; O in red). (c) Representation of the MPD of TRPV1 highlighting the residues interacting
with DPPA molecules. (d) Multiple sequence alignment for human sequences containing the LSRKF
motif (STX, syntaxin; matrillin 1 or cartilage matrix protein (MATN1)). The color code for MSA and
structure residue representation is the following: red, negatively charged; blue, positively charged;
white, polar non-charged; green, non-polar.
TRPV channels are trafficked via constitutive and SNARE-dependent regulated exocytosis [6].
TRPV1 and TRPV2 have been shown to interact with SNARE binding vesicular proteins, such as
SytIX and Snapin [10,11]. Our data indicate that the conserved MPD is involved in this interaction.
Derived from our data and taking into account the sequence conservation within the MPD and
the three-dimensional structure of TRPV channels, there is a region within the MPD, which could
be a putative SNARE-binding protein motif (Figure 4a). The MPD consists of two structural
regions, the Leu-Ser-Arg-Lys-Phe (LSRKF) motif (in the N-terminal region of the MPD) and the
more hydrophobic bilayer proximal fork-domain interacting with the TRP domain (Figure 4a–c).
The LSRKF motif contains the LSRKF fingerprint, which can be found in a few human proteins
(Figure 4d), among those, TRPV1–4 and syntaxins (STX) 1a, 1b, 2, and 3. STX1a and STX1b are present
in excitatory cells, whereas STX2 and STX3 are ubiquitously expressed [17], but in any case they bind
to SNARE proteins such as Syt and Snapin. The LSRKF motif is present in the exocytosis-specific
N-terminal domain of the mentioned STXs [18]. Further biochemical studies comparing STX and
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MPD peptides could explain the role of the LSRKF motif and protein–protein interactions, key to
understanding the SNARE-dependent exocytosis/trafficking of TRPV channels.
It is known that STX1a interacts with high affinity with the phospholipase D signaling metabolite
PA via a polybasic domain [19]. The hydrophobic fork-domain within the MPD (Figure 4a) contains
a polybasic region putatively capable of lipid binding [15]. Research on TRPVs has shown that the
C-terminus region of TRPV channels binds PA [20]. TRPV1 Lys710 in the TRP-domain has been shown
to interact with PA, modulating its activity. Our study, although in vitro, is the first to show interaction
of an N-terminus region of TRPV1 and TRPV2 with PA (Figure 2). In our study, the interaction of
the MPD with PA is higher than with PC or PG, especially from the Trp quenching experiments.
Although both PA and PG have negatively charged polar headgroups, the stronger interaction with PA
may come from the smaller headgroup for PA, but also from the higher reactivity of PA as a function
of pH [21]. In Figure 4c, we show a model for TRPV1 embedded in a dipalmitoylphosphatidylcholine
(DPPC)/DPPA lipid bilayer. This model shows that, among the positively charged residues in the
fork domain, Arg428, Lys431, Arg432, and Lys710 (in the C-terminus) in TRPV1 are within interaction
distance with DPPA molecules (Figure 4c).
As most channels [22], TRPV1–4 channel function is modulated by lipid composition, especially by
Phosphatidylinositol 4,5-bisphosphate (PIP2) through phospholipase C [23,24]. PA, as a cone shape
lipid, exerts dramatic effects on membrane curvature and membrane fusion properties [25,26],
key parameters to drive exocytosis. PA binding domains, such as the MPD in TRPV1–4 channels may
be responsible for stabilizing the channel on closed conformation in PA-rich membranes, as happens
with certain potassium channels [27]. Taking into account that TRPV1–4 cation channels are heat
and mechanosensors [7], these proteins require an inactivation mechanism preventing cation flux
through the channel during trafficking, which may lead to cation-toxicity (e.g., intracellular Ca2+
load). Thus, the strong specific binding of the TRPV1 and TRPV2 MPD in vitro (Figure 2) may
indicate that MPD–lipid interaction is critical for the proper trafficking of the protein. In fact, the MPD
domain is critical for the folding, assembly, and trafficking of oligomeric TRPV4 channels [28] via the
interaction with the TRP domain (for clarity see Figure 4b,c). Our results indicate that the MPD domain
without the TRP domain is not capable of driving self-oligomerization as shown by our SAXS data
indicating monomeric species (Figure 3b,c). Further, in vitro characterization of MPD-TRP domain
oligomerization could be relevant to determine the inter-domain interaction potential within the N-
and C-terminus in TRP channels.
As a summary, we provide an in vitro biophysical characterization of the MPD for TRPV1
and TRPV2, a conserved domain among TRPV1–4 channels, revealing protein-protein and
lipid-protein interaction features, which could be translated into the understanding of the molecular
mechanism of these somatosensory channels in their physiopathological modulation by lipids [29,30],
protein binding [11], and trafficking [6].
4. Materials and Methods
4.1. DNA Plasmids and Cloning
TRPV2 cDNA were cloned into a pcDNA3 vector in frame with an enhanced-GFP (eGFP) and
8XHis-tags at the C-terminus. The N-terminus truncation for TRPV2, ∆ARD-TRPV2 (∆1-336 rat
TRPV2), was cloned by high-fidelity PCR amplification followed by ligation into the same pcDNA3
vector within NdeI and NotI sites. The MPD for TRPV1 and TRPV2 (MPD) sequences were purchased
from GenScript (New Jersey, NY, USA) and cloned into pTTQ18-superfolder-GFP (sfGFP) plasmid
within EcoRI-PstI sites.
4.2. Recombinant Protein Expression and Purification
MPD1 or MPD2 were overexpressed as fusion proteins containing an Human Rhinovirus 3C
Protease (HRV3C) cleavage site followed by the sfGFP and a decahistidine tag (10× His) in the
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C-terminal. Proteins were expressed in E. coli BL21 cells in Luria Bertani (LB) media supplemented with
ampicillin, and induced with 1 mM isopropyl β- D -1-thiogalactopyranoside (IPTG) at OD600 ≈ 0.6,
overnight at 37 ◦C. Cells were collected by centrifugation (4000× g for 30 min), resuspended in
20 mM Tris·HCl (pH 8), 150 mM NaCl, 5% glycerol, pelleted again at 4000× g for 30 min, and stored
at −80 ◦C. For lysis, cell pellets were resuspended in 20 mM Tris·HCl (pH 8), 150 mM NaCl, 5%
glicerol, 2 mg/mL lysozyme, supplemented with protease inhibitors (0.5 µg/mL pepstatin, 1 mM
4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF), 5 mM benzamidine, and 1 Complete
EDTA-free tablet (Roche, Germany) for each 50 mL), and stirred on ice for 20 min at 4 ◦C.
Cell suspension was sonicated for 5 cycles of 30 s pulse followed by 30 s pause. The resulting lysate
was centrifuged for 30 min at 24,000× g and the supernatant was collected and filtered through a 45 µm
filter (Millipore, Germany). For purification, Talon (GE Healthcare, Germany) beads were equilibrated
with 20 mM Tris·HCl (pH 8), 150 mM NaCl, 5% glicerol, and 5 mM imidazole and incubated with
the filtrated supernatant for 1 h at 4 ◦C in stirring. Beads were washed with 20 column-volumes of
20 mM Tris·HCl (pH 8), 150 mM NaCl, 5% glicerol, and 20 mM imidazole, and proteins were eluted
with 6 column-volumes of 20 mM Tris·HCl (pH 8), 150 mM NaCl, 5% glicerol, and 250 mM imidazole.
The eluted protein was concentrated using a Centricon filter (3 kDa MW, Sartorius, Germany) to a final
volume of 500 µL.
4.3. Cell Cultures and Transfection
HEK293 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Spain)
supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 100 µg/mL
streptomycin. Transfection was performed using polyethyleneimine (PEI, Polysciences, 23966,
Germany). HEK293 cells overexpressing the transfected constructs were lysed 48 h after transfection,
and membrane proteins were solubilized for 30 min at 4 ◦C in lysis buffer (50 mM Tris-HCL pH 7.4,
150 mM NaCl, 2 mM EDTA, 1% Triton, 5% glycerol, 1 mM benzamidine, and EDTA-free protease
inhibition cocktail, ROCHE 11873580001, Germany). Cell extracts were centrifuged at 14000× g at 4 ◦C
for 10 min to remove aggregates.
4.4. Immunoblotting
Lysates and immunoprecipitates were loaded into SDS-page gels and run at 100 mV for
90 min. Gels were transferred to nitrocellulose membranes into a semi-dry cast at 100 mA for
1 h. Membranes were blocked in blocking buffer (5% non-fat-dry milk TTBS 1×) ON at 4 ◦C.
Primary antibodies were incubated in blocking buffer for 1 h at room temperature. Primary antibodies
were diluted as follows: anti-MYC tag (551101, Pharmingen, Germany) 1:1000, anti-GFP tag (GFP-G1,
DSHB, Iowa, IA, USA) 1:1000. Secondary antibodies were incubated in blocking buffer for 1 h at RT.
Anti mouse (sc-2031, SantaCruz, Dallas, TX, USA) and anti rabbit (sc-2030, SantaCruz, Dallas, TX, USA)
were used at 1:2000. Membranes were developed with Luminata crescendo reagent (WBLUR0100,
Millipore, Germany).
4.5. Co-Immunoprecipitation
Soluble fractions from cell lysates were used as input for co-immunoprecipitations. Cell extracts
at 1 µg/ul (500 µg total protein) were incubated overnight at 4 ◦C with anti-MYC antibody (551101,
Pharmingen, Germany). Immuno-complexes were then incubated with 50 uL of sepharose beads
(17-0618-01, GE Healthcare, Germany) for 2 h at 4 ◦C. After incubation, the complexes were washed
with lysis buffer 3 times. Immunoprecipitated complexes were then denatured with SDS-PAGE sample
buffer (90 ◦C for 5 min), separated by SDS-PAGE and analyzed by western blotting.
4.6. Pull Down
MPD from TRPV1 and TRPV2 were purified from E. coli as described above. Purified MPDs
were added to Hek293 cell lysates from Snapinand Synaptotagmin-IX MYC-tagged transfected cells.
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Cell extracts at 1 ug/uL (500ug total protein) were incubated 2 h at 4 ◦C and then incubated with
50 uL of GFP-trap A beads (gta-10, Chromotek, Germany) for 2 h at 4 ◦C. After incubation, the beads
were washed with lysis buffer 3 times, denatured with SDS-PAGE sample buffer (90 ◦C for 5 min),
separated by SDS-PAGE, and further analyzed by immunoblot.
4.7. Lipid Strips
Lipids were resuspended in a 1:2:1 parts Chloroform-Methanol-Water buffer. Solubilized lipids
were diluted in 1:2:1 parts of a Chloroform-Methanol-Tris·HCl 50 mM buffer and spotted into
a nitrocellulose membrane at the desired final concentrations of 0, 50, 100, or 200 µM. Membranes
were dried at RT for 1 h and then stored at 4 ◦C ready to use. Membranes were blocked for 1 h at RT
with blocking buffer (2% bovine serum albumin (BSA) PBS 1×) and incubated with purified protein,
free GFP, MPD1-GFP, or MPD2-GFP, at 9.5 µg/mL in a blocking buffer for 1 h at RT. After incubation
membranes were washed 3 times in Tween20- tris-buffered saline TTBS 1× and further analyzed by
immunoblot against a GFP tag.
4.8. Tryptophan Quenching
For the liposomes generation, we departed from a chloroform solution of each phospholipid.
The required volume was deposited on a ball rotavapor (Rotavapor R-3000, Büchi, Switzerland)
to obtain a final concentration of 1.5 mM lipid in the final suspension. The solution was dried in
a rotavapor to obtain a film of phospholipid, which was further resuspended in 2 mL/ball of 50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, 10% glycerol, and EDTA-free protease inhibitors. Agitation in
a rotavapor was performed in order to hydrate phospholipids to form a suspension containing large
multilamellar liposomes. Tryptophan endogenous fluorescence, excitation at 280 nm and emission
at 332 nm, was measured using a PTI Quantamaster fluorimeter (PTI, Canada). Proteins in 50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, and 10% glycerol were incubated in a quartz cuvette and lipids
reconstituted in the protein buffer were added at increasing concentrations.
4.9. SAXS Data
SAXS data were collected at the Non-Crystalline Diffraction beamline at the ALBA-CELLS
synchrotron light source, (Cerdanyola del Vallés, Barcelona, Spain). For each protein (20 mg/mL),
60 frames of a 1 s exposure time were collected. The X-ray beam energy was at 12.4 keV, and the
sample to detector distance was 6.25 m. Background was checked before and after each frameset to
monitor radiation damage.
Initial data reduction was carried out using SAXSIT [31]. Images were circularly integrated to
yield an averaged and reduced linear I(S) versus S plots. All the scattering measurements were checked
before the averaging and subtraction of the buffer solution. Data were corrected for sample transmission,
background, and detector sensitivity and were normalized to the scattering cross-section per unit sample
volume I(S). PRIMUS and GNOM software [32,33] was applied to process the experimental data and
further to evaluate the P(r). Ab initio modeling was done using DAMMIN software [34]. PRIMUS,
GNOM and DAMMIN are available at https://www.embl-hamburg.de/biosaxs/.
4.10. MSA and Tridimensional Representations
LSRKF motif containing sequences have been identified using BLASTP [35] against human
sequences. MSA was performed with MAFFT [36] and depicted using JalView [37]. Protein-membrane
bilayer system was prepared in CHARMM-GUI [38]. Tridimensional structure representations have
been done using VMD [39].
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/3/682/
s1.
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Abbreviations
MPD Membrane proximal domain
TRP Transient receptor potential
TRPV Transient receptor potential vanilloid
SNARE
GFP
Stx
Syt
PLD
PA
PI
PI4P
PC
PS
PG
SNAP (Soluble N-ethylmaleimide-sensitive factor Attachment Protein) REceptor
Green fluorescent protein
Syntaxins
Synaptotagmin
Phospholipase D
Phosphatidic acid
Phosphatidylinositol
Phosphatidylinositol 4-phosphate
Phosphatidylcholine
Phosphatidylserine
Phosphatidylglycerol
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